big pharma

In response to Merck’s announcement that it has granted a license for its promising COVID-19 pill to the Medicines Patent Pool, Robbie Silverman, Oxfam America’s Senior Manager for Private Sector Engagement, made the following statement:

“Merck’s move to license molnupiravir is welcome as it could indeed mean increased access to its promising COVID-19 drug in the poorest countries in the world.

Responding to an International Labour Organisation’s report, ILO Monitor: COVID-19 and the world of work, campaigners have called global vaccine inequality “a collective act of social and economic self-harm”.

On the eve of President Biden’s global COVID-19 summit on the side-lines of the UN General Assembly, campaigners from the People’s Vaccine Alliance are calling for world leaders to go beyond empty promises of charity and deliver bold action to increase manufacturing and access to COVID-19 vaccines around the world.

More than 140 former heads of state and government and Nobel laureates today called on the candidates to be the next German chancellor Annalena Baerbock, Olaf Scholz, and Armin Laschet to declare themselves in favour of waiving intellectual property rules for COVID-19 vaccines and transferring vaccine technologies, and “to make these the policies of any future coalition government”. 

The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren’t profiteering from their monopolies on COVID-19 vaccines, campaigners from the People’s Vaccine Alliance said today.

Responding to the announcement that COVAX has received more funding and is planning to accelerate its vaccine rollout, Oxfam International’s Head of Inequality Policy, Max Lawson, said: “More funding for COVAX and a quicker rollout of vaccines is a small piece of good news for developing countries struggling to get the doses they need, but at best fewer than a quarter of people in these countries will have been vaccinated by the end of the year."

Max Lawson, Head of Inequality Policy at Oxfam, said: "This G7 summit will live on in infamy. Faced with the biggest health emergency in a century and a climate catastrophe that is destroying our planet, they have completely failed to meet the challenges of our times. Never in the history of the G7 has there been a bigger gap between their actions and the needs of the world."

Responding to news that G7 leaders are collectively planning to pledge at least 1 billion COVID-19 vaccine doses to poorer countries, Oxfam's Health Policy Manager Anna Marriott said: "If the best G7 leaders can manage is to donate 1 billion vaccine doses then this summit will have been a failure. It is estimated that the world will need 11 billion doses to end the pandemic."

Responding to early reports of G7 leaders agreeing a 'Carbis Bay Declaration' to end future pandemics faster, Oxfam's Health Policy Manager Anna Marriott said: "It's welcome that G7 leaders are planning measures to end future pandemics faster, but the lack of urgent action to end the current crisis is unforgiveable."

Anna Marriott, Oxfam Health Policy Manager and Policy co-lead for the People’s Vaccine Alliance said: "The 2021 Global Health Summit ended today in danger of being judged an historical failure of global solidarity to tackle a Covid-19 pandemic that is still, around the world, in its first expanding phase and yet to peak."